phenobarbital has been researched along with alprostadil in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Coon, MJ; Kupfer, D; Theoharides, AD; Vatsis, KP | 1 |
| Buko, VU; Sadovnichy, VV | 1 |
| Chen, HW; Li, CC; Lii, CK; Liu, KL; Shen, HL; Yang, JJ | 1 |
| Chen, HW; Li, CC; Lii, CK; Liu, KL; Yang, JJ | 1 |
7 other study(ies) available for phenobarbital and alprostadil
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Hydroxylation of prostaglandins by inducible isozymes of rabbit liver microsomal cytochrome P-450. Participation of cytochrome b5.
Topics: Alprostadil; Animals; Cytochrome b Group; Cytochromes b5; Hydroxylation; Isoenzymes; Kinetics; Microsomes, Liver; Phenobarbital; Prostaglandins; Prostaglandins E; Rabbits | 1982 |
Cytochrome P-450 and free radical generation in rat liver microsomes under the influence of prostaglandin E1.
Topics: Acetone; Alprostadil; Animals; Cytochrome P-450 CYP2B1; Cytochrome P-450 CYP2E1; Down-Regulation; Ethanol; Free Radicals; Hydrogen Peroxide; Luminescent Measurements; Male; Microsomes, Liver; NADH, NADPH Oxidoreductases; NADP; NADPH Oxidases; Phenobarbital; Rats; Rats, Inbred Strains; Starvation; Superoxide Dismutase | 1996 |
Prostaglandin E2 down-regulation of cytochrome P-450 2B1 expression induced by phenobarbital is through EP2 receptor in rat hepatocytes.
Topics: Adenylyl Cyclases; Alprostadil; Animals; Cells, Cultured; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclooxygenase 1; Cyclooxygenase 2; Cytochrome P-450 CYP2B1; Dinoprostone; Down-Regulation; Gene Expression Regulation; Hepatocytes; Male; Membrane Proteins; Phenobarbital; Prostaglandin-Endoperoxide Synthases; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP2 Subtype; RNA, Messenger | 2005 |
n-6 and n-3 polyunsaturated fatty acids down-regulate cytochrome P-450 2B1 gene expression induced by phenobarbital in primary rat hepatocytes.
Topics: Adenylyl Cyclase Inhibitors; Alprostadil; Animals; Arachidonic Acid; Cyclic AMP-Dependent Protein Kinases; Cyclooxygenase Inhibitors; Cytochrome P-450 CYP2B1; Dinoprostone; Docosahexaenoic Acids; Down-Regulation; Enzyme Inhibitors; Fatty Acids, Omega-3; Fatty Acids, Omega-6; Gene Expression; Hepatocytes; Indomethacin; L-Lactate Dehydrogenase; Male; Phenobarbital; Rats; Rats, Sprague-Dawley | 2006 |